Abstract
Purpose
To study the effects of tezosentan, a dual ETA and ETB receptor antagonist on the cardiopulmonary profile in a fetal lamb model of CDH in utero.
Methods
A diaphragmatic hernia was surgically created at day 75 of gestation. During a 45 min of tezosentan perfusion (1 mg/kg), hemodynamic parameters (pulmonary and aortic pressures, left pulmonary and aortic flows, left auricle pressure, heart rate) were measured at day 135 of gestation. Age-matched fetal lambs served as control animals. Secondarily, parietal tension of vessels rings of pulmonary arteries was assessed in organ baths under increasing concentration of tezosentan.
Results
In CDH group, under perfusion of tezosentan, pulmonary artery pressure decreased from 45.8 ± 4.1 to 37.6 ± 5.9 mmHg (P < 0.05). Pulmonary artery flow and pulmonary vascular resistance remained constant. In control group, pulmonary artery flow increased from 153.9 ± 15.8 to 233.4 ± 26 ml/min (P < 0.05). Pulmonary artery pressure did not vary. Subsequently calculated pulmonary vascular resistance decreased. In organ bath, no significant relaxation was observed.
Conclusion
In this fetal lamb model of CDH, tezosentan decreased pulmonary artery pressure but did not modify pulmonary blood flow. Endothelin may play a role in the regulation of pulmonary vascular tone in utero.
Similar content being viewed by others
References
Kitagawa M, Hislop A, Boyden EA, Reid L (1971) Lung hypoplasia in congenital diaphragmatic hernia: a quantitative study of airway, artery and alveolar development. Br J Surg 58:342–346
Geggel RL, Murphy JD, Langleben D, Crone RK, Vacanti JP, Reid LM (1985) Congenital diaphragmatic hernia: arterial structural changes and persistent pulmonary hypertension after surgical repair. J Pediatr 107:457–464
Naeye RL, Ladis B, Grage JS (1976) Unsuspected pulmonary vascular abnormalities associated with diaphragmatic hernia. Pediatrics 58:902–906
Starrett RW, de Lorimier AA (1975) Congenital diaphragmatic hernia in lambs: hemodynamic and ventilatory changes with breathing. J Pediatr Surg 10:575–582
Olivet RT, Rupp WM, Telander RL, Kaye MP (1978) Hemodynamics of congenital diaphragmatic hernia in lambs. J Pediatr Surg 13:231–235
Mohseni-Bod H, Bohn D (2007) Pulmonary hypertension in congenital diaphragmatic hernia. Semin Pediatr Surg 16:126–133
Kobayashi H, Puri P (1994) Plasma endothelin levels in congenital diaphragmatic hernia. J Pediatr Surg 29:1258–1261
de Lagausie P, de Buys-Roessingh A, Ferkdadji L, Saada J, Aisenfisz S, Martinez-Vinson C, Fund X, Cayuela JM, Peuchmaur M, Mercier JC, Berrebi D (2005) Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol 205:112–118
Kavanagh M, Battistini B, Jean S, Crochetière J, Fournier L, Wessale J, Opgenorth TJ, Cloutier R, Major D (2001) Effect of ABT-627 (A-147627), a potent selective ET(A) receptor antagonist, on the cardiopulmonary profile of newborn lambs with surgically-induced diaphragmatic hernia. Br J Pharmacol 134:1679–1688
Thébaud B, de Lagausie P, Forgues D, Aigrain Y, Mercier JC, Dinh-Xuan AT (2000) ET(A)-receptor blockade and ET(B)-receptor stimulation in experimental congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol 278:L923–L932
Okazaki T, Sharma HS, McCune SK, Tibboel D (1998) Pulmonary vascular balance in congenital diaphragmatic hernia: enhanced endothelin-1 gene expression as a possible cause of pulmonary vasoconstriction. J Pediatr Surg 33:81–84
Shinkai T, Shima H, Solari V, Puri P (2005) Expression of vasoactive mediators during mechanical ventilation in nitrofen-induced diaphragmatic hernia in rats. Pediatr Surg Int 21:143–147
Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vaoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415
Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y (1988) Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 10:249–252
Wagner OF, Christ G, Wotja J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhaeusl W, Binder BR (1992) Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 267:16066–16068
Hosoda K, Nakao K, Hiroshi-Arai, Suga S, Ogawa Y, Mukoyama M, Shirakami G, Saito Y, Nakanishi S, Imura H (1991) Cloning and expression of human endothelin-1 receptor c-DNA. FEBS Lett 287:23–26
de Nucci G, Thomas R, D’Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR (1988) Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:9797–9800
Clozel M, Gray GA, Breu V, Loeffler BM, Osterwalder R (1992) The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo. Biochem Biophys Res Commun 186:867–873
Fukuroda T, Fujikawa T, Ozaki S, Ishikawa K, Yano M, Nishikibe M (1994) Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun 199:1461–1465
Ivy D, Le Cras TD, Parker TA, Zenge JP, Jakkula M, Markham NE, Kinsella JP, Abman SH (2000) Developmental changes in endothelin expression and activity in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 278:L785–L793
Wojciak-Stothard B, Haworth SG (2006) Perinatal changes in pulmonary vascular endothelial function. Pharmacol Ther 109:78–91
Clozel M, Ramuz H, Clozel JP, Breu V, Hess P, Loeffler BM, Coassolo P, Roux S (1999) Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use. J Pharmacol Exp Ther 290:840–846
Fitzgerald RK, Oishi P, Ovadia B, Ross GA, Reinhartz O, Johengen MJ, Fineman JR (2004) Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension. Pediatr Crit Care Med 5:571–577
Geiger R, Pajk W, Neu N, Maier S, Kleinsasser A, Fratz S, Navarro-Psiha S, Fisher V, Treml B, Loeckinger A (2006) Tezosentan decreases pulmonary artery pressure and improves survival rate in an animal model of meconium aspiration. Pediatr Res 59:147–150
Rolland PH, de Lagausie P, Stathopoulos E, Leprêtre O, Viudes G, Gorincour G, Hery G, de Magnée C, Paut O, Guys JM (2008) Phasic hemodynamics and reverse blood flows in the aortic isthmus and pulmonary arteries of preterm lambs with pulmonary vascular dysfunction. Am J Phys Heart Circ Physiol 295:H2231–H2241
MacCumber MW, Ross CA, Glaser BM, Snyder SH (1989) Endothelin: visualization of mRNAs by in situ hybridisation provides evidence for local action. Proc Natl Acad Sci USA 86:7285–7289
Ivy DD, Kinsella JP, Abman SH (1994) Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest 93:2141–2148
Wong J, Fineman JR, Heymann MA (1994) the role of endothelin and endothelin receptor subtyper in regulation of fetal pulmonary vascular tone. Pediatr Res 35:664–670
Wang Y, Coceani F (1992) Isolated pulmonary resistance vessels from fetal lambs. Contractile behavior and responses to indomethacin and endothelin-1. Cric Res 71:320–330
Davenport AP, O’Reilly G, Kuc RE (1995) Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: a majority of ETA sub-type. Br J Pharmacol 114:1110–1116
Russell FD, Davenport AP (1995) Characterization of endothelin receptors in the human pulmonary vasculature using bosentan, SB2096870, and 97–139. J Cardio Pharmacol 26:S346–S347
Kavanagh M, Seaborn T, Crochetière J, Fournier L, Battistini B, Piedboeuf B, Major D (2005) Modulating effect of a selective endothelin A receptor antagonist on pulmonary endothelin system protein expression in experimental diaphragmatic hernia. J Pediatr Surg 40:1382–1389
Kent GM, Olley PM, Creighton RE, Dobbinson T, Bryan MH, Symchych P, Zingg W, Cummings JN (1972) Hemodynamic and pulmonary changes following surgical creation of a diaphragmatic hernia in fetal lambs. Surgery 72:427–433
Rutherford RA, Wharton J, McCarthy A, Gordon L, Sullivan MH, Elder MG, Polak JM (1993) Differential localization of endothelin ETA and ETB bonding sites in human placenta. Br J Pharmacol 109:544–552
Poston L (1997) The control of blood flow to the placenta. Exp Physiol 82:377–387
Kinsella JP, Ivy DD, Abman SH (2005) Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late and chronic pulmonary hypertension. Semin Perinatol 29:123–128
Soma S, Takahashi H, Muramatsu M, Oka M, Fukuchi Y (1999) Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. Am J Respir Cell Mol Biol 20:620–630
North AJ, Moya FR, Mysore MR, Thomas VL, Wells LB, Wu LC, Shaul PW (1995) Pulmonary endothelial nitric oxide synthase gene expression is decreased in a rat model of congenital diaphragmatic hernia. Am J Respir Cell Mol Biol 13:676–682
Karamanoukian HL, Peay T, Love JE, Abdel-Rahman E, Dandonna P, Azizkham RG, Glick PL (1996) Decreased pulmonary nitric oxide synthase activity in the rat model of congenital diaphragmatic hernia. J Pediatr Surg 31:1016–1019
Irish MS, Glick PL, Russel J, Kapur P, Bambini DA, Holm BA, Steinhorn RH (1998) Contractile properties of intralobar pulmonary arteries and veins in the fetal lamb model of congenital diaphragmatic hernia. J Pediatr Surg 33:921–928
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stathopoulos, E., Rolland, PH., Héry, G. et al. Acute effect of a dual ETA–ETB receptor antagonist on pulmonary arterial vasculature in preterm lamb fetuses with surgically induced diaphragmatic hernia. Pediatr Surg Int 27, 295–301 (2011). https://doi.org/10.1007/s00383-010-2668-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-010-2668-4